Genetic polymorphisms of human cytosol glutathione S-transferases and prostate cancer. (January 2008)

• Record Type: Journal Article
• Authors: Katoh, Takahiko; Yamano, Yuko; Tsuji, Mayumi; Watanabe, Masatoshi
• Is Part Of: Pharmacogenomics. Volume 9:Number 1(2008)
• Page Start: 93
• Page End: 104
• Publication Date: 2008-01
• Subjects: cancer -- glutathione transferase -- GST -- methylation -- polymorphism -- prostate -- SNP; Pharmacogenomics -- Periodicals; 615.1
• DOI: 10.2217/14622416.9.1.93
• Languages: English
• ISSNs: 1462-2416

Abstract

Glutathione S -transferases (GSTs) are involved in the metabolism of a wide range of carcinogenic chemicals. In humans, cytosol GSTs are divided into eight classes: αα (GSTA), µµ (GSTM), ππ (GSTP), θθ (GSTT), ττ (GSTZ), σσ (GSTS), οο (GSTO) and κκ (GSTK). The allelic polymorphism of these enzymes is associated with variations in enzyme activity; hence, it may affect the concentration of activated carcinogenic chemicals in the body. In addition to the metabolism of chemical carcinogens, GSTs metabolize steroid hormones, compounds in the diet and other agents potentially involved in prostate carcinogenesis. Three genetic polymorphisms of GSTs, GSTM1*0 (null), GSTT1*0 (null) and GSTP1 A313G, have been well documented. No consistent associations between GSTM1, GSTT1 or GSTP1 genotypes and prostate cancer have been observed. Recent meta-analysis reports show that these polymorphisms of GSTM1, GSTT1 and GSTP1 are unlikely to be major determinants of susceptibility to prostate cancer.